US Patent Issued to The Research Foundation for The State University of New York on June 3 for "5-halouracil-modified microRNAs and their use in the treatment of cancer" (New York Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,913, issued on June 3, was assigned to The Research Foundation for The State University of New York (Albany, N.Y.).

"5-halouracil-modified microRNAs and their use in the treatment of cancer" was invented by Jingfang Ju (East Setauket, N.Y.), Andrew Fesler (Sound Beach, N.Y.), Younghwa Song (Port Jefferson Station, N.Y.) and Jun Chung (Setauket, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides nucleic acid compositions that incorporate one or more halouracil molecules. More specifically, the present disclosure reveals that the replacement of uracil nucleotides within a microRNA nucleotide sequence with a 5-halouracil...